NEWSLETTER June 2021

to advance education and research in the science of www.bap.org.uk for the public benefit

INSIDE 1 Message from the BAP President Message from the BAP President 2–3 Summer Meeting 2021 4–8 2021 I am delighted to report that Election for BAP Officers and Council our forthcoming 2021 Summer Members 8 Attitudes Towards Lithium Meeting, which will be held as a Project - Survey; 2021 Membership virtual event from Monday 19 to Subscriptions 9–10 The Unexpected Wednesday 21 July, contains all the usual exciting sessions. All the Benefits of Remote Working 10 VPM symposia planned for last year have been transferred Library 11 Media Activity 12 Education into the programme and will each include latest Events updates in their field. In addition to the usual Clinical and Non-Clinical sessions we have a special session discussing the impact of Covid-19 on mental health. All talks will be pre-recorded and available to members for a fixed period after the meeting. We are delighted to have received over 120 abstracts demonstrating the continued commitment to psychopharmacology British Association for research despite challenging times. I am particularly Psychopharmacology grateful that you have chosen the BAP as a forum to present this work. To maximise interaction between 36 Cambridge Place delegates, poster presenters will be asked to pre- Hills Road record a short oral explanation of their work which Cambridge CB2 1NS will become available the week prior to the meeting, with live question and answer during timetabled 01223 358 395 poster sessions. In addition to our usual poster prizes Executive Officer we have also introduced a ‘peoples prize’ voted for by Susan Chandler • [email protected] you, the delegates, for your favourite poster. I want to Assistant to the Executive Officer give special thanks to Sarah Channing-Wright (BAP) Lynne Harmer • [email protected] and Peter Tysoe (Stream Projects) who have built the Online Resources and Communications Developer BAP Live Online system so effectively to enable all Sarah Channing-Wright • [email protected] these sessions at our 2021 summer meeting to occur. Registration for BAP Training and student members For m @BAPsych is free, so please encourage the junior researchers in your group to take advantage of this opportunity. BritishAssociationforPsychopharmacology We may have to wait until 2022 for the disco and Gala Dinner to return, but I am confident that this /company/britishassociationforpsychopharmacology Summer Meeting will deliver the high-quality science that it is renowned for. The British Association for Psychopharmacology is registered in England as a Private Company No 5866899. Kevin Fone Registered Charity No 277825. HIGHLIGHTS 9 Invited Symposia 3 Post-Doctoral Symposia ⚫⚫ Non-invasive neurostimulation treatments ⚫⚫ The next phase of computational psychiatry: from first episode to treatment-resistant broader applications and novel methods depression: clinical efficacy and mechanisms ⚫⚫ Heterogeneity in psychiatric illness: How far of action are we from personalised medicine? ⚫⚫ Big data approaches to understanding mental ⚫⚫ Predictive factors of adolescent mental health disorders and treatment response and translational implications of predictive ⚫⚫ Chronic Fatigue Syndrome – Biological testing determinants and pathways to treatment Plenary Symposium, Monday 19 July ⚫⚫ Mapping impulsivity and compulsivity: phenotypes, cognitive markers, neural domains Suicide: from basic to clinical science and treatment Suicide is an individual tragedy and a public health ⚫⚫ Enabling translational psychopharmacology issue of major proportions. In this session leading through preclinical MR technology international experts will review the basic science of suicide in terms of neuroscientific and related ⚫⚫ Does research on body-brain interactions processes; the clinical aspects with reference to hold promise for the development of novel the latest data driven approaches and the clinical treatments for addiction and eating disorders? psychopharmacology of antisuicidal treatments. ⚫⚫ What can computational analyses of brain imaging data tell us about mechanisms in Trainees’ Workshop, Tuesday 20 July psychiatric disorders? Funding and Fellowships ⚫⚫ Social neuropeptides: Central oxytocin and The BAP wants to support early career researchers vasopressin pathways and translational and trainees develop a career in psychopharmacology implications and translational research. This workshop will ⚫⚫ Cognitive impairment in mood disorders - a consider the value of an early career fellowship/ forgotten pharmacological target? new investigator funding, a discussion of funding opportunities in this area, what makes for successful applications and networking opportunity with people who hold both non-clinical and clinical fellowships.

2 June 2021 Clinical Session, Wednesday 21 July translatability, or perhaps whether primate research, specifically in cortical regions, will be more fruitful. Are we getting closer to translatability in New techniques are allowing greater dissection of neuropsychiatric research? neuronal pathways and mechanisms involved in The panel will describe work based on the model of psychiatric disease and may yield more targetted experience dependent plasticity and brain dynamics approaches to therapy. Finally, one of the challenges in response to sensory stimuli and pharmacological across all areas of biomedical research has been challenge in the context of neurodevelopmental reproducibility. A number of industry-academic conditions such as autism (ASC). Dr Eva Loth will partnerships have been established to look at ways to describe the background and approach to the AIMS- improve the methodology and translational relevance 2-TRIALS project structures. Dr Judit Ciarrusta will of animal research - but are we getting any closer to describe her work on the biological underpinning of translatability? brain vulnerability to neurodevelopmental conditions in early infancy. Dr Nicolaas Puts will describe how Special Session, Wednesday 21 July methods (edited MRS of GABA) and COVID-19 Current Research transcranial magnetic stimulation can be used to examine the relationship between neurotransmitter SARS-CoV-2 infection, and the pandemic, are having concentration, GABA-receptor function, quantifiable substantial and diverse effects on mental and brain aspects of altered sensory perception, and health. This symposium will explore and discuss these clinical manifestations of ASC. Professor Grainne issues. Tom Nicholson will provide an overview of the McAlonan will provide an overview of current of COVID-19, and Max Taquet will clinical psychopharmacology in ASC as well as present electronic health records data on the incidence pharmacological responsivity in the adult ASC brain. and relative risks of psychiatric and neurological She will discuss how these approaches contribute disorders after COVID-19. Cognitive impairment and to work within AIMS-2-TRIALS (the world’s largest ‘brain fog’ are increasingly of concern in COVID-19 grant for ASC) to identify causal mechanisms in ASC survivors, and Adam Hampshire will show how and novel intervention targets. online cognitive assessments are shedding light on the severity and of these difficulties. Finally, Non-Clinical Session, Wednesday 21 July Cath Harmer will present novel data suggesting that statins influence resilience to depression during the Innovative medicine approaches for pandemic. The session will include plenty of time for neurodevelopmental disorders discussion. Translation of biomedical research into the clinic is a problem across all areas of research. For two decades the apparent failure of animal models For more information and to register, go to to deliver new treatments has been discussed. www.bap.org.uk/BAP2021 This symposium aims to address whether new developments in rodent models can deliver improved

June 2021 3 2021 Election for BAP Officers Two Elected Council Member posts and Council Members (Post 1) Dr Sameer Jauhar has held this post as a casual vacancy for one year. The deadline for nominations for two Officer and two (Post 2) Dr Tom Freeman will retire from council. Council seats has now passed. Three nominations were received: Honorary General Secretary Sameer Jauhar Dr Peter Talbot will retire from Council. Steven Marwaha One nomination was received for the post of Honoary Digby Quested General Secretary, so Professor Rachel Upthegrove will be elected unopposed. Read Rachel’s statement Read all candidates’ statements below. below. Voting is online via the website only at www.bap.org.uk/vote and will close on MONDAY 28 Secretary for Non-Clinical External JUNE. The results will be announced at the electronic Affairs Annual General Meeting in July. Dr Sarah Bailey will retire from council. The BAP aims to represent the interests of all psychopharmacologists. Council asks Members to bear this One nomination was received for the post of Secretary in mind when voting, to ensure a balance of expertise. Please for Non-Clinical External Affairs, so Dr Maddy King refer to the BAP Equality, Diversity and Inclusion Statement will be elected unopposed. Read Maddy’s statement www.bap.org.uk/equality.php below. Current Officers and Council See website for biographies www.bap.org.uk/council

ELECTED OFFICERS ELECTED COUNCIL MEMBERS

Professor Kevin Fone Dr Sameer Jauhar President (Post 1) Dr Tom Freeman Professor David Baldwin (Post 2) President-Elect Professor Rachel Upthegrove Professor Allan Young (Post 3) Past-President Dr Oliver Robinson Dr Michael Browning (Post 4) Honorary Treasurer Dr Maddy King (Post 5) Dr James Stone Dr Anthony Vernon Meetings Secretary (Post 6) Dr Peter Talbot Dr Susannah Murphy Honorary General Secretary (Post 7) Dr Michael Bloomfield Dr Golam Khandaker Secretary for Clinical External Affairs (Post 8)

Dr Sarah Bailey OTHER VOTING MEMBERS OF COUNCIL Secretary for Non-Clinical External Affairs Dr Declan Jones

4 June 2021 Officer Nominees’ Statements

Rachel Upthegrove Statement of Intent University of Birmingham Given my past experience and ongoing clinical, training and research work, I am well placed to represent the Proposer: Dr Peter Talbot full BAP membership as Honorary General Secretary. Seconder: Professor David Baldwin Our strength is in the multidisciplinary nature of I qualified in BAP with clinical and preclinical, pharmacy and Medicine at the industry representation working to the highest Royal Free Hospital scientific and ethical standards, and through this School of Medicine, we have the best chance to develop new treatments University of London and improve therapeutic options. Diversity, as well in 1993, and after as membership numbers, need to remain in focus two years in general and I will work hard to assist the President, Council medicine completed and Executive Officer with plans to expand the BAP’s my psychiatry reach in to new communities of active clinical and training and PhD in non-clinical members. Upholding the necessary legal Birmingham. I am now a Professor of Psychiatry and requirements and records are also important parts Youth Mental Health at the University of Birmingham, of the role and I believe I can bring enthusiasm and and Consultant Psychiatrist in the Birmingham energy to these practical aspects of the role. Early Intervention Services. My research interest is within early phases of schizophrenia, co-morbidity Maddy King and the development of the evidence for repurposed and novel, stage specific, treatments. I continue to University of Nottingham work actively in psychosis services and in this clinical Proposer: Dr Michael Bloomfield work I see day to day the challenges resulting from Seconder: Professor David Baldwin a paucity of therapeutic options for people with psychosis, and the need for new pharmaceuticals I am a Senior Research particularly targeted to symptoms rather than Fellow in the School categorical diagnoses. of Life Sciences at the University I am active in undergraduate and post graduate of Nottingham. teaching, including MBChB, MSc, clinical academic My involvement fellows and PhD students. Since 2018 I have actively with preclinical contributed to BAP Masterclasses and the Clinical psychopharmacology Certificate Schizophrenia Module. I have been a began in 2000 with member of BAP for many years, and have personally an undergraduate benefited tremendously from BAP outputs, CPD, placement at the Merck Sharp & Dohme guidance and publications so it is a delight to now be Neuroscience Research Centre. I obtained an MSci able to contribute to these. I have enjoyed being active in Pharmacology from the University of Bath in 2002, in the structure and function of BAP and have been then moved to Nottingham where I completed my on Council since elected in 2018. I aim to continue industry-funded PhD in 2007. I was a post-doctoral to work hard to maintain the clinical relevance in researcher on a multicentre EU FP6 funded project our work, high-quality guidelines, information, before appointment to my current role in 2010. education and training for practicing clinicians from all disciplines. I aim to ensure my on-going coal face Throughout my career I have studied a range clinical practice helps keep this accessible, realistic of neuropsychiatric problems using integrated and relevant to the real-world setting. animal behavioural, neurochemical and molecular

June 2021 5 approaches. I have collaborated successfully to Council later the same year. On Council I helped at the interface of academia and industry and to organise the 2021 online Summer Meeting and believe this is central to the continued viability of am coordinating the Buddy Scheme to support the psychopharmacology research in the UK. training members who are key to our future. I will be exploring options to improve retention of these Statement of Intent members, and to update delivery of the Certificate in Non-Clinical Psychopharmacology to make it more I have been an active member of the BAP for nearly 20 accessible. If elected as Secretary for Non-Clinical years. I joined at the start of my PhD and have since External Affairs I will: attended all but one of the Summer Meetings to share findings and make new contacts. Whilst a junior ⚫⚫ Build on the fantastic core ethos of BAP to member I benefited from excellent training via the BAP stimulate preclinical-clinical and academic- Certificate in Non-Clinical Psychopharmacology. In industrial interaction, and promote more recent years I thoroughly enjoyed opportunities interdisciplinary collaboration. to train and mentor early career researchers through ⚫⚫ Support ongoing initiatives related to the this course, as well as the Summer Meeting Buddy 3Rs and Concordat on Openness on Animal Scheme and In Vivo Training Initiative. I received the Research Senior Non-Clinical Award in 2019 and was elected

Council Nominees’ Statements

Sameer Jauhar A recent interest of mine has been communicating with the public and media about the treatments we King’s College London offer in psychiatry, through the Science Media Centre, Proposer: Professor David Baldwin BBC Radio 4, various blogs, and the interesting social Seconder: Professor Allan Young media phenomenon that is Twitter. I graduated in I have worked as a Consultant Psychiatrist within Medicine from Early Intervention Services since 2012, currently Glasgow University working half-time within the NHS, and half-time in in 2002, also funded research and teaching role. completing a degree in Public Health Statement of Intent and Epidemiology. My contact with BAP dates back to a Masterclass I completed my in Schizophrenia which I attended in 2005, and psychiatry training since then I have enjoyed attendance at annual in Glasgow, where I meetings and perusing the “Green” Journal (Journal briefly worked as a Consultant Psychiatrist. Having of Psychopharmacology). Recently, I was fortunate failed in various fellowship applications I moved to enough to be considered, and awarded the BAP the IoP in 2012, to undertake PET imaging studies Senior Clinical Award (2019). of the dopamine system in psychosis, completing My reasoning for standing for Council is that I believe a PhD from these studies. My current research in the ethos of BAP, from its multi-disciplinary interests focus on examining the dopamine system working to the broader issue of psychopharmacology in affective psychoses, as well as treatments and their advancing clinical care-and wish to contribute to the effectiveness in affective and psychotic disorders. continued success of our organisation.

6 June 2021 Steven Marwaha Statement of Intent University of Birmingham I first joined the BAP after I qualified as a Consultant Psychiatrist in 2005 and attended all the Core Proposer: Professor Rachel Upthegrove Certificates. I found them impressive and evidence Seconder: Dr Golam Khandaker based and a superb resource for the management of mental illness. Since then, I’ve used most of the I am a Professor BAP evidence guidelines in my clinical practice. of Psychiatry at I’ve represented the BAP and contributed to its the University work in interactions with the National Institute of of Birmingham, Clinical Excellence. If elected my priorities would and a Consultant be to support the investigation of effectiveness of Psychiatrist. I medications and other physical treatments, and studied Medicine in the synthesis of results to aid BAP guidelines. at the University Secondly, I’d fully support the BAP in providing of Cambridge and a strong voice in national consultations and University College organisations, and improving the public discourse London, and did my psychiatric training in North around psychopharmacology. I would also like to London, where I also worked as a Clinical Lecturer further develop the BAP’s connections with patient in Psychiatry. I then moved to Warwick University to groups and charities that could support the BAP, take up a Senior Lecturer post in Psychiatry, before clinician’s and researcher’s work. taking up my current post in Birmingham. My current main interests are in early intervention, Digby Quested epidemiology, and trials of treatments for people with mood disorders, with a particular focus on University of Oxford bipolar disorder and treatment resistant depression. Proposer: Professor Paul Harrison I also have a track record of researching the biology, psychology, measurement and epidemiology of mood Seconder: Professor Catherine Harmer dysregulation as a transdiagnostic process. I have As a general adult researched ways of improving the clinical outcomes psychiatrist, I of people with established mood disorders using data value excellence in science and the use of large epidemiological datasets prescribing through to understand medication use, and in developing and different phases of testing pharmacological (and other physical e.g rTMS) care. The BAP became interventions. Notable currently funded research an important part of includes leading a national randomised controlled my training during trial of stimulant vs non-stimulant use in adults with my MD in Oxford ADHD and co-morbid Bipolar Disorder or Psychosis under Phil Cowen (the SNAPPER trial), developing a data driven after psychiatry training in London. This had research platform for treatment resistant depression, included posts at the Maudsley Hospital and Charing and investigating the psychiatric impacts of Long- Cross rotation posts with a fellowship investigating COVID, including possible immune signatures of schizophrenia aetiology. I also worked on a thought symptom profiles, and possible treatment. disorder scale and its testing using PET with IOP and Clinically I work as a Consultant Psychiatrist in Charing Cross Hospital colleagues. Birmingham and Solihull Mental Health Trust, and After my MD in serotonin receptor mechanisms, run a Specialist Mood Disorders Clinic there. as a new consultant/hon senior clinical lecturer in Oxford I set up a gene/environment study with UCL,

June 2021 7 investigating environmental light influence in the Statement of Intent perinatal period in schizophrenia, while the DNA Psychopharmacology has now been a stimulating samples are included in GWAS studies. I am PI for focus over two decades with the BAP central to it, as I MIAMI-UK, a recently published RCT of melatonin have regularly attended and presented at the Summer in acute (funded by NIHR) and have published Meeting. systematic reviews of melatonin in mood and actigraphy in bipolar. A senior fellowship sabbatical I have gained from other events run by the BAP such has supported the work up of a linked Phase 3 RCT as the excellent guideline launch seminars and from application. the energy and thought put into ensuring the Summer Meeting remains an exciting mark in the neuroscience Educationally - I coordinated the MRCPsych Course calendar. The meetings are also remarkable for in Oxford for eight years, emphasising biological successfully linking people at different times in their psychiatry and lectured on anti-psychotics and careers, forging collaborations and teams. I encourage gene/environmental aspects of psychosis. As PI for younger researchers into studies, and attendance at schizophrenia and bipolar disorder studies I have BAP meetings, many of whom have later followed enjoyed supervising many trainees, including on psychiatric or research careers. The BAP successfully placements from abroad, and local students starting fuses learning with innovation but at a scale which is research. Alongside this I chair a clinical/academic both personal and yet a critical mass. It fosters interest psychopharmacology case forum where trainees and competitive involvement, incentivised by the prizes present, with clinical and academic colleagues, and Fellowship awards, one of which I appreciated students and some non-clinical colleagues attending receiving. I have applied as I would very much like to to participate in clinical decision making. contribute to the above as a member of Council

Attitudes Towards Lithium 2021 Membership Project - Survey Subscriptions The ISBD Lithium Task Force is currently conducting Members who do not pay their annual subscription a survey to collect psychiatrists’ personal concepts, by Standing Order will soon have received five opinions and experiences on the clinical use of lithium requests for payment to be made by alternative in maintenance treatment of bipolar disorders. means. Anyone who can prescribe lithium are asked to Those who remain unpaid on will be complete this brief survey. The survey will take just 25 June removed from the membership list so that correct 10-15 minutes to complete. figures can be presented at the AGM. https://enquesta.clinic.cat/index.php/563737

8 June 2021 The Unexpected Benefits of keep up to date with the wider field. Since meetings were held online, we’ve been able to hear seminars from international Remote Working speakers – something that wasn’t as frequent before.” Ava Mason and Paul Jung, PhD Students, UCL Ava has also found that regular lab meetings, journal clubs and online socials have minimised the sense Remote working during the pandemic has been a of a PhD being an isolating experience. “Thankfully, unique experience for Paul Jung, a second year PhD the weekly lab team meetings have made it easier to set student, and Ava Mason, a first year PhD student at targets and goals that are communicated well to other staff the UCL Division of Psychiatry. members, providing Paul, describes his a consistent way of experiences of remote updating on current working from a progress and, therefore, different continent. maintaining a base “The second year of level of motivation. The my PhD has been very additional journal clubs, different to my first year. where recent research I had spent the first year papers are discussed of my PhD working in an within the field, and office in London. Now, I training workshops to am remote working from Paul Jung improve transferable Ava Mason Seoul. As a hotdesker, skills, have made it the largest distance between my desk and my supervisor’s easier to network with other members of the department. was just a few metres - now, it’s a few thousand!”. They have also made each week vary, and reduced the sense Ava has been remote working without having ever of a PhD being an isolating experience. Having PhD cohort visited the office. “As a first-year student starting a PhD meetings and virtual kitchen catchups also provide a good remotely, it can be difficult to associate yourself with an support system, where I can meet new staff members in a institute without having ventured into any of the buildings less formal environment and get to know some of the other or offices. However, the experience has brought some PhD students.” unexpected positives. For instance, increased confidence Though there have been challenges that have required in communicating research through regular meetings and novel solutions, remote working has also enabled new public speaking presentations, when discussing topics in the opportunities for communication and collaboration. comfort of my own home. This works as a stepping stone to Paul describes how online research has enabled many public speaking, that will make the experience less daunting of these opportunities. “We were fortunate in that we had when in-person contact hours increase.” experience with conducting studies on online experimental Despite the distancing, Paul and Ava have been platforms, meaning that we were able to continue our able to maintain a sense of being a team by being in research. Online research has also enabled collaboration regular contact with other team members and the with other groups – we’ve been able to add a Korean arm wider institute. “Though I’m in a different continent and to one of our studies, and I’ve been collaborating with an timezone, by meeting regularly with the team in weekly Australian team with similar research interests. Meetings lab meetings and other meetings and seminars within being conducted online have meant that we’ve also been able the institute, I’ve been able to maintain a sense of being a to communicate and share ideas with experts from all over team. Having regular meetings scheduled, even if we didn’t the world, and keeping up to date with the field has been necessarily have anything significant to discuss, has meant more natural and easier than before.” that we’ve felt connected and updated with what everyone Ava also describes how remote working has enabled in the lab is working on, and has ensured we have a space new opportunities for communication and learning. to discuss potential solutions for any problems anyone “From this experience of remote working, I have increased is encountering. Weekly journal club, where we discuss my ability to use various platforms (e.g. Zoom and Microsoft recently published papers, and seminars, have enabled us to Teams) in order to communicate research effectively. It

June 2021 9 has also been a challenge in efficiency, and occasionally, directly see them. From this experience, I have learned to motivation, where I have learned how to manage my time take opportunities to contact researchers who will expand in an environment where others aren’t working around me. my knowledge, without considering their work destination While virtual working can reduce the social contact you as a barrier.” have with colleagues within the department, it also provides “Though it has been a challenging year, remote work has an opportunity to set up meetings with individuals you given us new perspectives that we hope to remember going wouldn’t have thought to connect with online beforehand. forwards. A sense of teamwork doesn’t just come from the For example, I have felt more confident in emailing group that you belong to or the institution you are associated academics on certain research topics and setting up virtual with, but also from a wider international scientific meetings to discuss queries, who I wouldn’t have thought community.” to contact when working in a department where I wouldn’t

VPM Library David Nutt It has now been over a year since the BAP took up hosting the new VPM visualisation system for psychotropic medicines. So I wonder, how many of you have used it? I have been using an image of each drug I talk about in both undergrad and medical postgrad lectures to clarify their pharmacology. The feedback from students has been universally very positive. So all you teachers (and self-teachers) please visit the site and see what it can do for your educational outputs! www.bap.org.uk/education_vpm

10 June 2021 Media Activity Barbara Sahakian 24th March 2021 The Conversation: A showcase for the media and public engagement activities of Psychedelic drugs: how the BAP members. brains of informed users Following are some of the latest members’ activities are different over the past few months. All members’ activities, Barbara Sahakian and George Savulich explain the with links, can be found at www.bap.org.uk/members difference between different types of drug users Ciara McCabe 29th April 2021 ITV: Giving Up Sugar: For Good? Tonight Ciara McCabe 16th February 2021 Ciara was on ITV talking about the Neuroscience of Independent: Why hobbies reward and what happens when we eat sugary things can improve our mental health Ciara explains how having David Nutt 15th April 2021 a hobby can help heal our minds during the pandemic BBC News: Psilocybin: Magic mushroom compound ‘promising’ for Ciara McCabe 14th February 2021 depression Telegraph: How to David Nutt and Robin Carhart-Harris share the latest kickstart your happiness findings of a small scale study hormones and beat the lockdown blues Ciara was interviewed in an article on dopamine and Barbara Sahakian 14th April 2021 reward How the coronavirus pandemic is changing us Barbara explains how the BAP on Twitter pandemic has changed our brain chemistry @BAPsych We regularly tweet information about our latest events and activities. We would be grateful if you could help us spread the word by re-tweeting.

Have you recently engaged with the public in science via the media or public events? Both the Medical Research Council and the advocate engagement with the public regarding scientific and medical research, and BAP is keen for members to engage with the media, so that we can share our important research findings with the public, including enthusiastic students and trainees. We would like to invite you to share your most recent media activities with us, so that we can disseminate them to the public through our website and social media. In particular we are looking for media articles, video interviews, podcasts, websites and blogs. Please send any links or other engagement with the media to Sarah Channing-Wright at [email protected].

June 2021 11 Education Events Certificate in Clinical Psychopharmacology

Overview Forthcoming Modules Psychopharmacology is the single most Drug Treatments in 9 September 2021 – commonly used treatment modality in BAP Live Online Affective Disorders 10 September 2021 psychiatry. It is vital we use drugs to their Substance Use and 16 September 2021 – optimal effect – matching our choices BAP Live Online and regimes to the needs and symptoms Addiction 17 September 2021 of patients whilst minimising side effects and avoiding adverse interactions Anxiety Disorders January 2022 Bristol with other drugs. New drugs and new Child and Adolescent ways of using old ones regularly appear. March 2022 Nottingham With ever increasing demands on our Psychopharmacology professional time it is difficult to keep up to date. This programme for CPD in Schizophrenia May 2022 Manchester state-of-the-art psychopharmacology is Drug Treatments in tailored to emphasise practical everyday October 2022 Newcastle problems encountered by all prescribing Old Age Psychiatry psychiatrists. Child and Adolescent October 2022 Newcastle Psychopharmacology Content includes: ⚫⚫ lectures Registration fees ⚫⚫ workshops BAP Live Online: £200 per module ⚫⚫ discussion sessions Face to Face: £390 per module To register interest in modules complete the form at www.bap.org.uk/interest Masterclasses in Clinical Psychopharmacology

Overview Forthcoming Masterclasses The Masterclasses are held over three consecutive BAP Live Online days, twice a year. You can register for one, two or all three days, depending on your needs Schizophrenia, Day A 24 November 2021 and interests. The full three day package is Substance Misuse intended to provide a state-of-the-art update in Bipolar, Perinatal, psychopharmacology for clinicians. Day B ADHD 25 November 2021 Content includes: Depression, Day C Anxiety, Sleep 26 November 2021 ⚫⚫ a review of the basic pharmacology of the relevant drugs ⚫⚫ the clinical use of those drugs Registration fees ⚫⚫ discussions around relevant BAP and NICE BAP Live Online: £150 per day guidelines To book a place go to www.bap.org.uk/masterclasses ⚫⚫ questions and discussion with the speakers

12 June 2021 CMHP Annual Conference

The College of Mental Health Pharmacy (CMHP) Abstracts selected for poster presentation will be 2021 annual international psychiatric pharmacy organised into the following categories: conference takes place from 8-9 October 2021 at ⚫⚫ Clinical audit the MacDonald Manchester Hotel in Manchester. With a mix of speakers to deliver keynote ⚫⚫ Service development/evaluation sessions, and we offer a mix of plenary sessions, ⚫⚫ Quality improvement workshops, presentations, poster sessions and ⚫⚫ table top discussions. Registration details are on Original research the website: At the conference, the best oral presentations and www.cmhp.org.uk/conference/conference-2021/ posters in each category will be selected for the CMHP awards. Call for posters and oral presentations The award-winning abstracts from each category The call for conference oral presentations and get published free to access online in the British poster abstract submissions is open with a closing Association for Psychopharmacology’s Journal of date of 29 June 2021. Psychopharmacology, making them available to a much wider audience. Oral presentations are delivered during a plenary session at conference as 15-minute talks For more details visit: by pharmacists and pharmacy technicians on www.cmhp.org.uk/conference/conference-2021/ research or practice-related projects.

June 2021 13 ONLINE CPD RESOURCE A high quality, up-to-date resource taught by top experts in their field

Schizophrenia Substance Misuse Including Comorbidity Bipolar Disorder Perinatal Disorders ADHD Focussing On Adult Depression Anxiety Disorders Sleep Old Age £120 Child and Adolescent per year General Psychopharmacology non-members

Reviews of recent psychopharmacology papers, regularly updated PLUS

Multiple Choice Questions, printable certificate £60 on completion and reading lists per year members and those who have registered or attended recent BAP meetings/courses

Also available on iPad £45 per year multiple users (10+)

For more information and to subscribe go to www.bap.org.uk/onlinecpd £30 per year RCPsych CPD FREE subscribers RPsych 14 June 2021 Trainees